Beta Bionics Cash Flow Statement 2023-2025 | BBNX

Fifteen years of historical annual cash flow statements for Beta Bionics (BBNX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023
$-54.76$-44.10
$2.28$2.09
$16.35$14.87
$18.63$16.96
$-7.62$-4.49
$-11.44$-1.19
$1.52$0.72
$-1.44$-2.17
$-12.15$-5.31
$-48.27$-32.45
$-3.35$-0.40
$0$0
$0$0
$-0.13$-69.30
$0$0
$-0.13$-69.30
$0$0
$-3.48$-69.69
$0$0
$0$0
$0$0
$0.10$0.03
$59.76$101
$0$0
$-4.15$0
$55.62$101
$3.87$-1.11
$6.38$5.66
$0$0